Preprint
Machine Learning

Molecular Docking and Structure-Based Drug Design Strategies

Leonardo L. G. Ferreira(Universidade de São Paulo), Ricardo Nascimento dos Santos(Universidade de São Paulo), Glaucius Oliva(Universidade Federal de São Carlos), Adriano D. Andricopulo(Universidade de São Paulo)
July 22, 2015Molecules2,492 citations

2.5k

Citations

49

Influential Citations

Molecules

Venue

2015

Year

Abstract

Pharmaceutical research has successfully incorporated a wealth of molecular modeling methods, within a variety of drug discovery programs, to study complex biological and chemical systems. The integration of computational and experimental strategies has been of great value in the identification and development of novel promising compounds. Broadly used in modern drug design, molecular docking methods explore the ligand conformations adopted within the binding sites of macromolecular targets. This approach also estimates the ligand-receptor binding free energy by evaluating critical phenomena involved in the intermolecular recognition process. Today, as a variety of docking algorithms are available, an understanding of the advantages and limitations of each method is of fundamental importance in the development of effective strategies and the generation of relevant results. The purpose of this review is to examine current molecular docking strategies used in drug discovery and medicinal chemistry, exploring the advances in the field and the role played by the integration of structure- and ligand-based methods.

Analysis

Why This Paper Matters

This review paper is a cornerstone reference in the field of computational drug discovery, as evidenced by its high citation count (2492). It systematically catalogs and compares molecular docking strategies, which are essential for predicting how small molecules (ligands) interact with biological targets (receptors). For AI practitioners, the paper underscores the critical role of computational methods in reducing the cost and time of drug development, and it highlights the need for robust algorithms that can accurately model the complex physics of molecular recognition.

The paper matters because it bridges the gap between computational chemistry and practical drug design. By discussing both structure-based and ligand-based methods, it provides a holistic view that is valuable for researchers developing AI models for virtual screening, binding affinity prediction, and de novo drug design. The emphasis on understanding the limitations of each docking algorithm is particularly relevant for machine learning practitioners who often rely on docking scores as features or ground truth.

Technical Contributions

  • Comprehensive survey of molecular docking algorithms and their underlying scoring functions.
  • Discussion of the integration of structure-based (e.g., docking into protein crystal structures) and ligand-based (e.g., pharmacophore modeling, QSAR) methods.
  • Analysis of key phenomena in intermolecular recognition, including conformational sampling, solvation effects, and entropy.
  • Identification of critical factors for successful docking campaigns, such as target flexibility and water molecule placement.
  • No new algorithms or datasets are introduced; the contribution is synthetic and educational.

Results

As a review paper, there are no novel experimental results or quantitative benchmarks. The paper's impact is measured by its citation count (2492) and its role as a reference for subsequent research. It does not report metrics like docking accuracy, enrichment factors, or AUC values for specific methods.

Significance

The broader impact of this paper lies in its educational value and its influence on the drug discovery community. It has helped standardize the vocabulary and conceptual framework for molecular docking, enabling more effective communication between computational chemists and experimental biologists. For AI researchers, the paper highlights the importance of domain knowledge in designing better models for drug-target interaction prediction. It also points to open challenges, such as handling protein flexibility and scoring function accuracy, which remain active areas of machine learning research.